Newsroom

22-02-2019

International suppliers meet at Accord Fawdon to celebrate growing together in partnership

Accord Fawdon recently hosted a special event to celebrate its supplier partnerships. 

Read More
12-02-2019

Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare

Taipei, Taiwan and Harrow, England, February 11, 2019 – An exclusive license agreement for the commercialisation of Foresee Pharmaceutical’s (6576.TWO) novel FP-001 program (leuprorelin depot), Leuprolide Mesylate Injectable Suspension (LMIS) ready-to-use subcutaneous depot formulations has been granted to Accord Healthcare.

Read More
08-02-2019

The Falsified Medicines Directive – Sandra Lee’s interview published in Pharmacy Business – February 2019 edition

Sandra Lee, Managing Director of Operations, explains why FMD is important and how the industry is preparing.

Read More
29-01-2019

Accord celebrates the one-year anniversary of the Fawdon factory

The team at Accord Fawdon recently celebrated the factory’s one-year anniversary with cakes and reflections on the successes of the past year.

Read More
14-01-2019

Accord and other leading voices in the pharmaceutical and financial industry debate how to drive consistent and long-term growth

In November 2018, at the House of Lords, Accord partnered Generics bulletin to bring influential

Read More
10-10-2018

ACCORD HEALTHCARE - THE MOST RECOGNISED COMPANY AT THE GLOBAL GENERICS & BIOSIMILAR AWARDS 2018

We are delighted to announce that Accord Healthcare was the most recognised company at the Global Generics & Biosimilar Awards 2018, having won awards for: Company of the Year and Biosimilar Initiative of the Year. 

Read More
27-07-2018

Accord Healthcare’s (Intas) Pelgraz® (pegfilgrastim) Given Green Light by CHMP

Pelgraz - a pegylated G-CSF Biosimilar, is latest addition to Accord Healthcare's established portfolio of over 30 oncology treatments across Europe  

Read More
12-06-2018

Continued growth in Europe

Over the past two weeks, we have continued to further our expansion in Europe with the opening of a new office in Basel, Switzerland and further expansion of operations in Austria.

Read More